- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Apr 30, 2025 | 29.76M sh |
| Long Term Debt | Q3 2025 · Mar 31, 2025 | $17.86M |
| Long Term Debt | Q3 2025 · Jun 30, 2024 | $26.72M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $886.29M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $891.61M |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $155.42M |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $154.23M |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $230.08M |
| Total Liabilities | Q3 2025 · Jun 30, 2024 | $253.41M |
| Current Assets | Q3 2025 · Mar 31, 2025 | $399.39M |
| Current Assets | Q3 2025 · Jun 30, 2024 | $398M |
| Total Assets | Q3 2025 · Mar 31, 2025 | $1.12B |
| Total Assets | Q3 2025 · Jun 30, 2024 | $1.15B |
| Net Income | Q3 2025 · Mar 31, 2025 | −$10.81M |
| Net Income | Q3 2025 · Mar 31, 2025 | −$19.92M |
| Cash And Equivalents | Q3 2025 · Jun 30, 2024 | $175.13M |
| Cash And Equivalents | Q3 2025 · Mar 31, 2024 | $174.39M |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 28.43M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 28.02M sh |
| Capex | Q3 2025 · Mar 31, 2024 | $29.76M |
| Operating Cash Flow | Q3 2025 · Mar 31, 2024 | $18.59M |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | −$0.39 |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | −$0.30 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | −$0.39 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | −$0.30 |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $22.96M |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $64.61M |
| Rd Expense | Q3 2025 · Mar 31, 2024 | $23.1M |
| Rd Expense | Q3 2025 · Mar 31, 2024 | $68.13M |
| Operating Income | Q3 2025 · Mar 31, 2024 | −$10.5M |
| Operating Income | Q3 2025 · Mar 31, 2024 | −$2.26M |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $35.56M |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $130.48M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $114.51M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $365.5M |
| Revenue | Q3 2025 · Mar 31, 2024 | $150.06M |
| Revenue | Q3 2025 · Mar 31, 2024 | $495.98M |